GENEVA, Sept. 30 -- SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (48 Itaewon-ro 55-gil,Yongsan-gu,Seoul 04348), 사회복지법인 삼성생명공익재단 (서울특별시용산구이태원로55길 48) filed a patent application (PCT/KR2024/021562) for "ANTICANCER ADJUVANT FOR CANCER IMMUNOTHERAPY AND COMPOSITION FOR INHIBITING CANCER METASTASIS COMPRISING EPIREGULIN INHIBITOR" on Dec 31, 2024. With publication no. WO/2025/198143, the details related to the patent application was published on Sep 25, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, w...